Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Health Network, Toronto | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this study is to evaluate the overall impact of Telehomecare on COPD and HF patients and system level outcomes using a comparison group of patients that did not participate in the program (for up to 18 months). This evaluation study will explore costs, participants' experiences, perceptions, and patterns of use related to Telehomecare. The study will include eight Local Health Integration Networks (LHINs) across Ontario, Canada.
The key question to answer is how different models of Telehomecare enabled self-management impacts patient outcomes, experiences and system costs across Ontario. The evaluation study will also attempt to answer questions on who is benefitting the most from the program and the quantifiable benefits a patient would experience from participating.
The intervention evaluation study will use a mixed-methods design comprising of four components (sub-studies), using both qualitative and quantitative research methods: (1) Comparative Effectiveness Study that evaluates patient-level clinical outcomes (e.g. hospitalization, ED visits) using administrative data in comparison with usual care; (2) Economic Evaluation Study that will evaluate costs associated with the program and patient level outcomes as well as cost-effectiveness of the program in comparison with 'usual care'; (3) Evaluation study of Telehomecare use that will evaluate the patterns of program use and perceived quality of life, disease management, satisfaction and caregiver strain; and (4) Adoption study that will use ethnographic fieldwork, semi-structured interviews (during and after program participation) and review of documentary sources to gain understanding of program adoption.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Telehomecare patients (matched cohort study) | COPD and HF patients in Telehomecare program (followed up to 18 months) | ||
| Usual-care patients (matched cohort study) | COPD and HF patients in 'usual care' (followed up to 18 months) | ||
| Telehomecare patients (observations, interviews and surveys) |
| ||
| Informal caregiver (observations, interviews and surveys) |
| ||
| Healthcare providers (observations, interviews and surveys) |
| ||
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Disease specific hospitalization and ED visits | Comparison of disease specific hospitalization and ED visits between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) | 18 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of all-cause hospitalization/ED visits | Comparison of the number of all-cause hospitalization/ED visits between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) | 18 months |
| Number of visits to primary care physicians |
| Measure | Description | Time Frame |
|---|---|---|
| Costs associated with Telehomecare equipment and services | Costs associated with Telehomecare equipment and services; comparison of health services costs for Telehomecare and 'usual care'; incremental cost-effectiveness ratio (ICER) of Telehomecare compared with 'usual care' | 18 months |
| Comparison of health services costs for Telehomecare and 'usual care' |
Inclusion Criteria:
Patient:
The patient has a documented diagnosis of HF or COPD (with or without co-morbid conditions);
The patient has been classified as a 'heavy user' of the health care system, characterized by any of the following:
Patient/informal caregiver (if applicable) is an adult (over 18 years), able and willing to provide informed consent;
Patient/informal caregiver (if applicable) is fluent in English;
Patient/informal caregiver is able and willing to operate the Telehomecare equipment; and
Patient lives in a residential (private home or retirement home) setting with an active landline.
In addition to the program eligibility criteria, the following criteria for the intervention evaluation study apply to recruitment of patients:
Healthcare Provider
A healthcare provider that has:
Technicians, Administrators, and/or Decision Makers
The following are eligible for inclusion in the study:
Exclusion Criteria:
Patient
Less than 18 years of age;
Individuals without an established diagnosis of COPD or HF
Unable or unwilling to provide verbal informed consent
Demonstrated non-adherence to the THC program:
o The Telehomecare Nurse works with each patient on a case-by-case review to assess willingness to partner in their own care, and if the number of missed consultation appointments and reasons for demonstrate overall non-adherence with the program;
Inability or unwillingness to use Telehomecare equipment, and/or;
Do not have a regular caregiver to assist in the use of the equipment (if assistance is required)
Healthcare Provider
Technicians, Administrators and/or Decision Makers
Not provided
Not provided
Not provided
This community based study will be conducted across 8 Local Health Integration Networks (LHINs) in Ontario: Toronto Central, North East, Central West, Erie St Claire, Central, North Simcoe Muskoka, North West and South West LHINs.
The study population will include COPD and HF patients that currently or previously participated in Telehomecare program. The study population will also include informal caregivers and healthcare providers involved in and/or caring for a patient enrolled in the program as well as administrators /decision makers involved with the Telehomecare program.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Valeria Rac, MD, PhD | Contact | 416-634-8799 | valeria.rac@theta.utoronto.ca | |
| Nida Shahid | Contact | 416-634-8804 | nida.shahid@theta.utoronto.ca |
| Name | Affiliation | Role |
|---|---|---|
| Valeria Rac, MD, PhD | University Health Network, Toronto | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Health Network | Recruiting | Toronto | Ontario | M5G 2C4 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Administrators and Decision Makers (observations, interviews) |
|
| Technician (observation, interviews) |
|
Comparison of the number of visits to primary care physicians between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months)
| 18 months |
| Number of visits to specialists | Comparison of the number of visits to specialists between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) | 18 months |
| Number of visits to in-home health professionals | Comparison of the number of visits to in-home health professionals between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) | 18 months |
| Number of admissions to long-term care facilities | Comparison of the number of admissions to long-term care facilities between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) | 18 months |
| Length of stay in hospital | Comparison of length-of-stay in hospital between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) | 18 months |
| Medication use | Comparison of medication use between patients receiving Telehomecare vs. 'usual care' (followed up to 18 months) | 18 months |
Costs associated with Telehomecare equipment and services; comparison of health services costs for Telehomecare and 'usual care'; incremental cost-effectiveness ratio (ICER) of Telehomecare compared with 'usual care' |
| 18 months |
| Incremental cost-effectiveness ratio (ICER) of Telehomecare compared with 'usual care' | Costs associated with Telehomecare equipment and services; comparison of health services costs for Telehomecare and 'usual care'; incremental cost-effectiveness ratio (ICER) of Telehomecare compared with 'usual care' | 18 months |
| Patterns of use of the program | Patterns of use of the program; patient quality of life, disease self-management skills and satisfaction with Telehomecare; Informal caregivers strain | 12 months |
| Patient quality of life, disease self-management skills and satisfaction with Telehomecare | Patterns of use of the program; patient quality of life, disease self-management skills and satisfaction with Telehomecare; Informal caregivers strain | 12 months |
| Informal caregivers strain | Patterns of use of the program; patient quality of life, disease self-management skills and satisfaction with Telehomecare; Informal caregivers strain | 12 months |
| Perceptions and experiences of patients | Perceptions and experiences of patients, informal caregivers, providers, administrators/decision-makers; overall adoption, integration and sustainability of the program | 12 months |
| Overall adoption, integration and sustainability of the program | Perceptions and experiences of patients, informal caregivers, providers, administrators/decision-makers; overall adoption, integration and sustainability of the program | 12 months |
| D012140 |
| Respiratory Tract Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |